RE:Trillium Therapeutics Investment Highlights as of Apr 5/17 It's amazing how this is under the mainstream's radar! Management needs to raise funds through another round and I'm sure financing at these SP prices is unsettling for management. One possible way to get the financing needed for phase 2 and 3 is to partner with a big pharma. I'm sure TRIL is being scoped. Who will pull the trigger?